1/15/2021Innovent's sNDA for Sintilimab as Second-line Therapy for Squamous NSC...

1/15/2021JPO Issues Bidding Documents for the Fourth Batch of VBP

1/15/2021Recent Executive Moves

1/14/2021NHSA Highlights Ten Major Tasks in 2021

1/14/2021Chiome and Henlius Sign Greater China Licensing Deal for Anti-TPOR-2 A...

1/14/2021What Do Novartis Deal, PD-1 Competition In China Mean For Tislelizumab...

1/14/2021Pharma Companies to Cut Prices of News Drugs by 51% to Access Chinese ...

1/13/2021Domestic PD-1s in the 2020 NRDL Negotiated Entry: Winners Take All

1/13/2021Sesen Bio and Qilu Pharma Announce Acceptance IND for Vicineum  in C...

1/13/2021BeiGene Granted Chinese Approval of Tislelizumab in Combo with Chemoth...

1/12/2021Swiss Re Sees Short-term Health insurance as Growth Driver in China

1/11/2021Chi-Med and Inmagene Announce Partnership for Portfolio of Drug Candi...

1/11/2021Strand Therapeutics and BeiGene Enter into Agreement to Develop Solid ...

1/11/2021NHSA Issues Two Interim Rules for Management of BMI Designated Medical...

1/8/2021Everest Medicines Announces CTA Approval for P3 Trial of Sacituzumab G...

1/8/2021Recent Executive Moves

1/8/2021SMCP - Coronavirus in China: 2021 Outlook Brightens for Health Care Op...

1/8/2021S&P Global: China's Big Tech to Continue Disruption of Healthcare Sect...

1/7/2021Apollomics Granted Breakthrough Therapy Designation for AML Drug APL-1...

1/6/2021NHC Issues Two New Documents on Public Hospital Management

1/6/2021Eli Lilly Granted Chinese Approval of Verzenio (Abemaciclib)

1/6/2021Immedica and Winhealth Sign Deal for UCD Drug Ravicti in Greater Chin...

1/6/2021Argenx and Zai Lab Enter Strategic Deal for Efgartigimod in Greater Ch...

1/5/2021Harbour BioMed Completes Its Global Offering and Listing on the HKSE

1/4/2021NMPA Signs MOU on Regulatory Cooperation with Italian Medicines Agenc...

1/4/2021Shanghai Pharma Breaks Ground on $1.8B Biotech Park Focused on Next-ge...

12/31/2020Data Analysis of Chinese Healthcare Spending and BMI System Finance 20...

12/30/2020TRACON Pharma's NDA for KN035 Accepted in China

12/30/2020Sinopharm Claims 79% Efficacy of Its COVID-19 Vaccine amid Transparenc...

12/30/2020China Grants Conditional Approval to Sinopharm Covid-19 Vaccine

Page:76/333 Total number of articles:9989: [First][<<] [74] [75] [76] [77] [78] [>>] [End]